ALT cannot be viewed as uniformly detrimental or beneficial; rather, its impact emerges from the dynamic interplay between tumor proliferation rate, chromatin architecture, immune microenvironment, and therapeutic vulnerabilities (Figure 3). Here, GPT is linked to neoplasm.